ASCO 2015 Highlights

Final Results of the CAIRO3 Study

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent

Prognostic Impact of Deficient Mismatch Repair in CRC

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent

Preoperative Chemoradiotherapy and Postoperative Chemotherapy in Locally Advanced Rectal Cancer—Results of the CAO/ARO/AIO-04 Trial

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent

RAS Mutation Status and FOLFOX +/- Cetuximab—The OPUS Study

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent

Pidilizumab in Relapsed Metastatic Melanoma

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Nivolumab and Erlotinib in EGFR-Mutation Positive Treatment-Resistant Advanced NSCLC

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Nivolumab in Chemotherapy-Naïve Advanced NSCLC

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Blinatumomab in Relapsed/Refractory Acute Lymphoblastic Leukemia

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Adoptive T-Cell Therapy for Cervical Cancer

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Pembrolizumab (MK-3745) in Metastatic Melanoma

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Page 226 of 329